Literature DB >> 8253344

Peroxynitrite-induced rat colitis--a new model of colonic inflammation.

D Rachmilewitz1, J S Stamler, F Karmeli, M E Mullins, D J Singel, J Loscalzo, R J Xavier, D K Podolsky.   

Abstract

BACKGROUND: Excessive production of nitric oxide, characteristic of inflamed states, may have deleterious effects through its facile conversion (in the presence of O2) to peroxynitrite, which promotes lipid and sulfhydryl oxidation. This study assessed the effect of peroxynitrite on the rat colon.
METHODS: Peroxynitrite was administered intrarectally to rats. One, 3, 7, and 21 days after treatment, a distal colonic segment was isolated and tissue was obtained for histological evaluation and determination of myeloperoxidase activity and NOX, and eicosanoids generation.
RESULTS: Within 24 hours, the exposed segment was edematous and congested with occasional hemorrhagic mucosal ulceration. On day 7, the lumen was narrow; at day 21, there were signs of stenosis. Histological analysis showed transmucosal necrosis, acute inflammation, and exudative edema 24 hours after treatment. Surface re-epithelization and infiltration of granulation tissue were present at 1 week. Resolution of edema, mucin repletion, thickening of muscularis mucosa and propria, and fibrosis were observed at 3 weeks. Significant increase in NOX generation and myeloperoxidase and NO synthase activities were observed at 24 hours, whereas enhanced leukotriene generation was observed only at 21 days.
CONCLUSIONS: Peroxynitrite-induced colonic inflammation provides a novel model of NO-related tissue injury and offers the opportunity to further explore the potential role of NO in the pathogenesis of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253344     DOI: 10.1016/0016-5085(93)91063-n

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

Review 1.  Peroxynitrite and inflammatory bowel disease.

Authors:  D M McCafferty
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  Functional genomics in gastroenterology.

Authors:  S Schreiber; J Hampe; H Eickhoff; H Lehrach
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 3.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Nitric oxide effect on colonocyte metabolism: co-action of sulfides and peroxide.

Authors:  W E Roediger; W J Babidge
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

5.  Protection against peroxynitrite dependent tyrosine nitration and alpha 1-antiproteinase inactivation by some anti-inflammatory drugs and by the antibiotic tetracycline.

Authors:  M Whiteman; H Kaur; B Halliwell
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

Review 6.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

7.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

8.  Hyperbaric oxygen: a novel modality to ameliorate experimental colitis.

Authors:  D Rachmilewitz; F Karmeli; E Okon; I Rubenstein; O S Better
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

9.  Protection against peroxynitrite-induced DNA damage by mesalamine: implications for anti-inflammation and anti-cancer activity.

Authors:  Paul M Graham; Jason Z Li; Xueging Dou; Hong Zhu; Hara P Misra; Zhenquan Jia; Yunbo Li
Journal:  Mol Cell Biochem       Date:  2013-03-26       Impact factor: 3.396

Review 10.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.